Click to Share
 

Myotonic Dystrophy Press Releases

Exclusive News
Topics Locations Industries Dates

12084947
By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share